12 results
DEF 14A
SLRN
Acelyrin Inc
22 Apr 24
Definitive proxy
4:10pm
and stock price appreciation targets, and designed to foster strong alignment between our employees and stockholder interests.
Time-based
10-K
2023 FY
SLRN
Acelyrin Inc
28 Mar 24
Annual report
4:21pm
meaningful, differentiated benefits for patients by improving upon the efficacy and/or safety of existing therapeutics directed against established targets … and policies agreed to by the FDA under PDUFA, the FDA targets ten months, from the filing date, in which to complete its initial review
10-Q
ypvj1jcr h6m1jhm
15 Jun 23
Quarterly report
4:19pm
424B4
cxqud681k03bu86ob
5 May 23
Prospectus supplement with pricing info
4:22pm
S-1/A
EX-10.14
3yqrzmxtebjbsf
1 May 23
IPO registration (amended)
6:10am
S-1/A
EX-10.3
60ho6abxt cc
1 May 23
IPO registration (amended)
6:10am
S-1/A
el8 a1t2cb
1 May 23
IPO registration (amended)
6:10am
S-1
7iojuihh01ue12riwswf
13 Apr 23
IPO registration
5:10pm
- Prev
- 1
- Next